Simultaneous Determination of Plasma Deferasirox and Deferasirox-Iron Complex Using an HPLC-UV System and Pharmacokinetics of Deferasirox in Patients with β-Thalassemia Major: Once-daily Versus Twice-daily Administration

MENG-YAO LUWang N.Wu W.-H.Lai C.-W.Kuo P.-H.Chiang P.-H.Lin K.-H.Wu T.-H.2020-12-162020-12-1620150149-2918https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940594044&doi=10.1016%2fj.clinthera.2015.05.506&partnerID=40&md5=d0eaf33867fa696c9c0f88d46bfab51ahttps://scholars.lib.ntu.edu.tw/handle/123456789/526415[SDGs]SDG3Simultaneous Determination of Plasma Deferasirox and Deferasirox-Iron Complex Using an HPLC-UV System and Pharmacokinetics of Deferasirox in Patients with β-Thalassemia Major: Once-daily Versus Twice-daily Administrationjournal article10.1016/j.clinthera.2015.05.506260938272-s2.0-84940594044